There is an urgent need to consider solutions to overcome complex access challenges to combination therapies — payers, policymakers and industry leaders must work together and act now to ensure access.
To mark the European Week Against Cancer, Euractiv met with Professor Jean-Yves Blay, Director of Public Policy for the European Society for Medical Oncology (ESMO) to assess what has been achieved to date and what is still on the ‘to do’ list for comb…
It’s the European Week Against Cancer (EWAC) and Euractiv is taking the opportunity to highlight the issue of rare cancers in this week’s Health Brief.
